Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-inflammatory agent 47

😃Good
Catalog No. T79480Cas No. 2925288-12-4

Flo8, an anti-inflammatory and antioxidant agent, effectively suppresses the release of reactive oxygen species (ROS) and nitric oxide (NO) while inhibiting neuronal apoptosis by modulating inflammatory and apoptotic signaling pathways, showcasing potential utility in Parkinson's Disease (PD) research [1].

Anti-inflammatory agent 47

Anti-inflammatory agent 47

😃Good
Catalog No. T79480Cas No. 2925288-12-4
Flo8, an anti-inflammatory and antioxidant agent, effectively suppresses the release of reactive oxygen species (ROS) and nitric oxide (NO) while inhibiting neuronal apoptosis by modulating inflammatory and apoptotic signaling pathways, showcasing potential utility in Parkinson's Disease (PD) research [1].
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$1,5206-8 weeks6-8 weeks
50 mg$1,9806-8 weeks6-8 weeks
100 mg$2,5006-8 weeks6-8 weeks
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
Flo8, an anti-inflammatory and antioxidant agent, effectively suppresses the release of reactive oxygen species (ROS) and nitric oxide (NO) while inhibiting neuronal apoptosis by modulating inflammatory and apoptotic signaling pathways, showcasing potential utility in Parkinson's Disease (PD) research [1].
In vitro
Compound Flo8, at concentrations of 5 μM and 10 μM administered for 18 hours, exhibited minimal inhibitory effects on the viability of BV2 microglial cells [1]. Furthermore, at a concentration of 5 μM over 18 hours, it significantly inhibited the production of reactive oxygen species (ROS) in BV2 cells [1]. The same concentrations of Compound Flo8 over 18 hours also reduced the expression of inflammatory cytokines in BV2 cells, consequently decreasing apoptosis levels in SH-SY5Y cells [1]. Additionally, Compound Flo8 inhibited M1 polarization and promoted M2 polarization in microglia following LPS induction at 5 μM and 10 μM for 18 hours [1]. It also suppressed the phosphorylation of ERK, p38, and JNK in BV2 cells induced by LPS [1].
In vivo
Compound Flo8 (15/35 mg/kg, intraperitoneal injection, daily/biweekly) alleviates neuroinflammation and inhibits neuronal apoptosis in the brains of MPTP-induced C57BL/6J mice [1].
Chemical Properties
Molecular Weight394.42
FormulaC25H18N2O3
Cas No.2925288-12-4
SmilesO=C1C=2C(=C(C=CC2)C3=NC(=NO3)C4=CC(C)=CC=C4)OC(=C1C)C5=CC=CC=C5
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Anti-inflammatory agent 47 | purchase Anti-inflammatory agent 47 | Anti-inflammatory agent 47 cost | order Anti-inflammatory agent 47 | Anti-inflammatory agent 47 chemical structure | Anti-inflammatory agent 47 in vivo | Anti-inflammatory agent 47 in vitro | Anti-inflammatory agent 47 formula | Anti-inflammatory agent 47 molecular weight